Cargando…

Social determinants of health impact mortality from HCC and cholangiocarcinoma: a population-based cohort study

The social determinants of health can pose barriers to accessing cancer screening and treatment and have been associated with cancer mortality. However, it is not clear whether area deprivation is independently associated with mortality in HCC and cholangiocarcinoma when controlling for individual-l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nephew, Lauren D., Gupta, Dipika, Carter, Allie, Desai, Archita P., Ghabril, Marwan, Patidar, Kavish R., Orman, Eric, Dziarski, Alisha, Chalasani, Naga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916098/ https://www.ncbi.nlm.nih.gov/pubmed/36757397 http://dx.doi.org/10.1097/HC9.0000000000000058

Ejemplares similares

Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis
por: Orman, Eric S., et al.
Publicado: (2019)

4295 The Impact of Social Determinants of Health on Hepatocellular Carcinoma Outcomes
por: Nephew, Lauren Devore, et al.
Publicado: (2020)

Association of State Medicaid Expansion With Racial/Ethnic Disparities in Liver Transplant Wait-listing in the United States
por: Nephew, Lauren D., et al.
Publicado: (2020)

Trends in Racial and Ethnic Disparities in the Receipt of Lifesaving Procedures for Hospitalized Patients With Decompensated Cirrhosis in the US, 2009-2018
por: Nephew, Lauren D., et al.
Publicado: (2023)

Extra-hepatic comorbidity burden significantly increases 90-day mortality in patients with cirrhosis and high model for endstage liver disease
por: Coppel, Scott, et al.
Publicado: (2020)

Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation
por: Mohamed, Kawthar A., et al.
Publicado: (2022)

Comorbidity Burden May Be Associated with Increased Mortality in Patients with Severe Acute Liver Injury Referred for Liver Transplantation
por: Steiner-Temnykh, Lindsey, et al.
Publicado: (2020)

Removal of medicaid restrictions were associated with increased hepatitis C virus treatment rates, but disparities persist
por: Nephew, Lauren D., et al.
Publicado: (2022)

Contemporary Trends in Hospitalizations for Comorbid Chronic Liver Disease and Substance Use Disorders
por: Desai, Archita P., et al.
Publicado: (2021)

Severe Alcohol‐Associated Hepatitis Is Associated With Worse Survival in Critically Ill Patients With Acute on Chronic Liver Failure
por: Patidar, Kavish R., et al.
Publicado: (2021)

Development and Validation of a Model to Predict Acute Kidney Injury in Hospitalized Patients With Cirrhosis
por: Patidar, Kavish R., et al.
Publicado: (2019)

Sex disparities in waitlisting and liver transplant for acute liver failure
por: Nephew, Lauren D., et al.
Publicado: (2020)

Longer time to recovery from acute kidney injury is associated with major adverse kidney events in patients with cirrhosis
por: Patidar, Kavish R., et al.
Publicado: (2023)

Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma Are Not Explained by Differences in Comorbidities, Liver Disease Severity, or Tumor Burden
por: Dakhoul, Lara, et al.
Publicado: (2018)

HLA-DR Mismatch and Black Race Are Associated With Recurrent Autoimmune Hepatitis After Liver Transplantation
por: McCabe, Marshall, et al.
Publicado: (2021)

Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation
por: Ngwa, Taiwo, et al.
Publicado: (2020)

Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals
por: Mukthinuthalapati, V. V. Pavan Kedar, et al.
Publicado: (2019)

Bleeding After Elective Interventional Endoscopic Procedures in a Large Cohort of Patients With Cirrhosis
por: Kundumadam, Shanker, et al.
Publicado: (2020)

3550 Understanding Racial Disparities in Hepatocellular Carcinoma Treatments and Outcomes
por: Nephew, Lauren Devore, et al.
Publicado: (2019)

Progressive Cholestasis and Biliary Cirrhosis After Initiating Oral Semaglutide: Report From the Drug-Induced Liver Injury Network
por: Ma, Jiayi, et al.
Publicado: (2022)

Serum Hepcidin Levels Are Associated With Obesity but Not Liver Disease
por: Vuppalanchi, Raj, et al.
Publicado: (2013)

The peptidoglycan recognition proteins (PGRPs)
por: Dziarski, Roman, et al.
Publicado: (2006)

HIV-1 Coinfection Profoundly Alters Intrahepatic Chemokine but Not Inflammatory Cytokine Profiles in HCV-Infected Subjects
por: Hu, Sishun, et al.
Publicado: (2014)

Liver Transplantation in Recipients With Class III Obesity: Posttransplant Outcomes and Weight Gain
por: Soma, Daiki, et al.
Publicado: (2022)

MELD–Na Is More Strongly Associated with Risk of Infection and Outcomes Than Other Characteristics of Patients with Cirrhosis
por: Fricker, Zachary P., et al.
Publicado: (2020)

Hepatic Ischemia/Reperfusion Injury After Liver Transplantation Is Not Associated with Early Impairment of Left Ventricular Ejection Fraction
por: Rokop, Zachary P., et al.
Publicado: (2022)

Surgical Strategies for Combined Hepatocellular-Cholangiocarcinoma (cHCC-CC)
por: Bahra, Marcus, et al.
Publicado: (2023)

Significant Medical Comorbidities Are Associated With Lower Causality Scores in Patients Presenting With Suspected Drug-Induced Liver Injury
por: Ghabril, Marwan, et al.
Publicado: (2020)

Differential Effects of Peptidoglycan Recognition Proteins on Experimental Atopic and Contact Dermatitis Mediated by Treg and Th17 Cells
por: Park, Shin Yong, et al.
Publicado: (2011)

Extrahepatic Autoimmune Diseases are Prevalent in Autoimmune Hepatitis Patients and Their First-Degree Relatives: Survey Study
por: Fogel, Rachel, et al.
Publicado: (2018)

Increasing Economic Burden in Hospitalized Patients With Cirrhosis: Analysis of a National Database
por: Desai, Archita P., et al.
Publicado: (2019)

Genetic Association of Peptidoglycan Recognition Protein Variants with Inflammatory Bowel Disease
por: Zulfiqar, Fareeha, et al.
Publicado: (2013)

Pglyrp-Regulated Gut Microflora Prevotella falsenii, Parabacteroides distasonis and Bacteroides eggerthii Enhance and Alistipes finegoldii Attenuates Colitis in Mice
por: Dziarski, Roman, et al.
Publicado: (2016)

Nod2 protects mice from inflammation and obesity-dependent liver cancer
por: Gurses, Serdar A., et al.
Publicado: (2020)

Changing Trends of Cirrhotic and Noncirrhotic Hepatocellular Carcinoma in the Era of Directly-Acting Antiviral Agents
por: Mathur, Karan, et al.
Publicado: (2021)

Author Correction: Nod2 and Nod2-regulated microbiota protect BALB/c mice from diet-induced obesity and metabolic dysfunction
por: Rodriguez-Nunez, Ivan, et al.
Publicado: (2018)

Nod2 and Nod2-regulated microbiota protect BALB/c mice from diet-induced obesity and metabolic dysfunction
por: Rodriguez-Nunez, Ivan, et al.
Publicado: (2017)

Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions
por: Stavraka, Chara, et al.
Publicado: (2018)

Peptidoglycan Recognition Proteins kill bacteria by inducing suicide through protein-sensing two-component systems
por: Kashyap, Des Raj, et al.
Publicado: (2011)

Formate dehydrogenase, ubiquinone, and cytochrome bd-I are required for peptidoglycan recognition protein-induced oxidative stress and killing in Escherichia coli
por: Kashyap, Des R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aptrglpvf8mu0lchn019hhp82d